

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 58.02 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 77.98 | Oscillator | Neutral |
| Williams %R (14) | -12.32 | Oscillator | Sell |
| MACD (12, 26, 9) | 1.80 (Hist 2.27) | Oscillator | Strong Buy |
| Average Directional Index (14) | 12.75 (+DI 19.4 / -DI 13.3) | Trend | Neutral |
| EMA 20 | 615.65 | MA | Buy |
| SMA 20 | 612.30 | MA | Strong Buy |
| EMA 50 | 606.40 | MA | Strong Buy |
| SMA 50 | 623.52 | MA | Buy |
| SMA 200 | 566.97 | MA | Strong Buy |
Current price $633.98
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 23, 26 | UBS | maintain | Buy | Buy |
| Oct 23, 26 | Stifel | maintain | Buy | Buy |
| Oct 21, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Oct 7, 26 | Citigroup | maintain | Neutral | Neutral |
| Oct 6, 26 | BNP Paribas | downgrade | Neutral | Underperform |
| Aug 11, 26 | Citigroup | maintain | Neutral | Neutral |
| Aug 7, 26 | JP Morgan | maintain | Overweight | Overweight |
| Aug 7, 26 | UBS | maintain | Buy | Buy |
| Jul 7, 26 | TD Cowen | maintain | Buy | Buy |
TTM vs. 5-year historical average (annual ratios)
| Metric | CACI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 25.9x | 20.3x · sector 44.2x | Discount |
| Forward P/E (FY27E) | 19.0x | EPS est. 33.43 | Discount |
| Price / Book | 3.0x | 2.5x | Elevated |
| Price / Sales | 1.4x | 1.2x | Elevated |
| EV / EBITDA | 16.5x | 13.9x | Elevated |
| Return on equity | 12.4% | — | Healthy |
| Gross margin | 21.6% | 13.4% | Above hist. |
| Debt / Equity | 1.14 | 0.79 | Moderate |
| Piotroski / Altman Z | 6/9 | Z 2.95 | Grey zone |
Discounted cash flow model
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 16, 26 | Blazer Eric | officer: SVP, Corp. Controller & CAO | M-Exempt | 590 | — |
| Oct 16, 26 | Blazer Eric | officer: SVP, Corp. Controller & CAO | M-Exempt | 99 | — |
| Oct 16, 26 | Blazer Eric | officer: SVP, Corp. Controller & CAO | F-InKind | 30 @ $614.31 | $18.43K |
| Oct 16, 26 | Blazer Eric | officer: SVP, Corp. Controller & CAO | F-InKind | 178 @ $614.31 | $109.3K |
| Oct 16, 26 | Blazer Eric | officer: SVP, Corp. Controller & CAO | M-Exempt | 590 | — |
| Oct 16, 26 | Blazer Eric | officer: SVP, Corp. Controller & CAO | M-Exempt | 99 | — |
| Oct 15, 26 | Nolan Philip O | director | A-Award | 328 | — |
| Oct 15, 26 | Disbrow Lisa S | director | A-Award | 50 | — |
Stock news · updated daily
CACI International (NYSE: CACI) reported first-quarter fiscal 2027 revenue growth of 8.2% and raised its full-year revenue and earnings outlook, citing strong awards activity, expanding funded backlog and demand for its technology-focused national security offerings. Revenue totaled $2.5 billion for the quarter, with organic growth of 2.1%, while adjusted diluted earnings per share increased 11.8% year
CACI International NYSE: CACI reported first-quarter fiscal 2027 revenue growth of 8.2% and raised its full-year revenue and earnings outlook, citing strong awards activity, expanding funded backlog and demand for its technology-focused national security offerings.
CACI International Inc ( CACI ) Q1 2027 Earnings Call October 22, 2026 8:00 AM EDT Company Participants George Price - Senior Vice President of Investor Relations John Mengucci - President, CEO & Director Jeffrey MacLauchlan - Executive VP, CFO, & Treasurer Conference Call Participants Sheila Kahyaoglu - Jefferies LLC, Research Division Gavin Parsons - UBS Investment Bank, Research Division John Godyn - Citigroup Inc., Research Division Matthew Marottolo - Melius Research LLC Peter Arment - Robert W. Baird & Co. Incorporated, Research Division Tobey Sommer - Truist Securities, Inc., Research Division Colin Canfield - Cantor Fitzgerald & Co., Research Division Gautam Khanna - TD Cowen, Research Division Christopher Barbero - JPMorgan Chase & Co, Research Division Joshua Korn - Wells Fargo Securities, LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by.
Although the revenue and EPS for CACI International (CACI) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CACI International (CACI) came out with quarterly earnings of $7.66 per share, beating the Zacks Consensus Estimate of $6.45 per share. This compares to earnings of $6.85 per share a year ago.
Revenues of $2.5 billion, up 8.2% YoY Net income of $130.4 million; Diluted EPS of $5.84, up 3.7% YoY Adjusted net income of $171.0 million; Adjusted diluted EPS of $7.66, up 11.8% YoY EBITDA of $328.8 million and EBITDA margin of 13.3% Contract awards of $4.8 billion and book-to-bill of 2.0x Raising fiscal year 2027 guidance for Revenue, Adjusted net income, and Adjusted EPS; reaffirming guidance for other financial metrics RESTON, Va., Oct. 21, 2026 /PRNewswire/ -- CACI International Inc (NYSE: CACI) announced results today for its fiscal first quarter ended September 30, 2026.
CACI International (NYSE: CACI - Get Free Report) and IBEX (NASDAQ: IBEX - Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Profitability This table compares CACI International and IBEX's net
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for CACI International (CACI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 21, 2026 | 6.57 | 7.66 | Beat 16.6% | $2.47B |
| Aug 5, 2026 | 7.39 | 8.91 | Beat 20.6% | $2.71B |
| Apr 22, 2026 | 6.90 | 7.27 | Beat 5.4% | $2.35B |
| Jan 21, 2026 | 6.41 | 6.81 | Beat 6.2% | $2.22B |
| Oct 22, 2025 | 6.15 | 6.85 | Beat 11.4% | $2.29B |
| Aug 6, 2025 | 6.55 | 8.40 | Beat 28.2% | $2.30B |
FY2026 · 10-K disclosure
FY2024 · 10-K disclosure
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 10-Q | Oct 22, 2026 | 2026-10-22 11:57:33 | View |
| 8-K | Oct 21, 2026 | 2026-10-21 16:45:47 | View |
| 8-K | Oct 21, 2026 | 2026-10-21 16:35:13 | View |
| 8-K | Oct 21, 2026 | 2026-10-21 14:32:55 | View |
| 4 | Oct 20, 2026 | 2026-10-20 13:49:54 | View |
| 4 | Oct 19, 2026 | 2026-10-19 16:41:25 | View |
| 4 | Oct 19, 2026 | 2026-10-19 16:41:17 | View |
| 4 | Oct 19, 2026 | 2026-10-19 16:41:11 | View |
| 4 | Oct 19, 2026 | 2026-10-19 16:41:05 | View |
| 4 | Oct 19, 2026 | 2026-10-19 16:40:59 | View |
Proxy statement (DEF 14A) disclosures